To further explore the role of CB1 receptors in diabetes, we explored whether the increased vasorelaxant effect seen in diabetes is related to a modulation of CB1 expression in aortic rings from diabetic rats and/or a change in the phosphorylation status of the receptor. The gene discussed is CNR1; the disease is diabetes mellitus.